11th February 2022
This International Day of Women and Girls in Science, Radhisha Kohombage, an MSc student at BCI, spoke to some fellow students, to hear more about their roles, inspirations, and advice for the next generation who would like to pursue a career in science.
Read more4th February 2022
Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute, Queen Mary University of London, has been working on a project to make information about screening programmes more accessible to minority ethnic groups in the UK.
Read more25th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Dr Angus Cameron, have found a way to modulate the invasive behaviour of pancreatic cancer by targeting a non-cancerous cell type found within pancreatic tumours. The findings, published in Cell Reports, provide valuable insights into the biology of pancreatic cancer progression, and could help to drive improvements in cancer treatment.
Read more6th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, the Moffitt Cancer Center and the University of Southern California, have developed a new method that measures subtle changes to the genetic code of cells (called DNA methylation) to study the dynamics of what happens to cells within our bodies over time. The new method, published in Nature Biotechnology, provides a way to measure the birth and death of human cells, making it possible to trace cell lineage and evolution.
Read more5th January 2022
Congratulations to Professor Nick Lemoine, Director of Barts Cancer Institute at Queen Mary University of London, who has received a CBE for services to clinical research, particularly during COVID-19.
Read more17th December 2021
In December each year, the American Society of Hematology (ASH) hosts its Annual Meeting and Exposition – the premier event in malignant and non-malignant haematology. The event represents an invaluable opportunity for researchers at Barts Cancer Institute, Queen Mary University of London to highlight their blood cancer research on an international stage.
Read more